Evidence map

TrialDiabetes, obesity & metabolism2013

Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes.

H J Lambers Heerspink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

374 papers cite itlatest 60 shown

2013
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

5 trials

Full record →Abstract, authors, funding and every citing paper · PMID 23668478